
Investor
General Catalyst
- AI
- Biotech
HQ: Cambridge, MA · Offices: San Francisco · New York
Overview
Invests in portfolio companies and acquired a hospital system to test a model for more proactive, accessible, affordable healthcare for American patients.
Part of the Boston ecosystem
Related
Bessemer Venture PartnersInvests in early and growth-stage companies, using market roadmaps to guide founders in areas such as software, fintech, digital health, consumer, and cybersecurity.
Spark CapitalInvests in companies and supports founders building products, including by leading venture rounds and helping shape brand identity projects with design partners.
Andreessen HorowitzInvests in seed through growth-stage technology companies and operates a venture support platform for founders needing help across company-building functions and stages.
Lux CapitalInvests in emerging science and technology companies and publishes scenarios, analyses, podcasts, and newsletters for audiences tracking strategic challenges and future developments.
Bloomberg BetaInvests in early-stage companies focused on making business work better, and publishes an open-source guide explaining how its fund operates.
First Round CapitalBacks founders and leads early investment rounds, often before company formation, while publishing stories about portfolio beginnings, product-market fit, and growth journeys.
Third Rock VenturesInvests in and helps create biotechnology and therapeutics companies, supporting portfolio businesses with company building and sharing updates on their development and transactions.
Energy Impact PartnersInvests in energy-focused companies and connects entrepreneurs with corporate partners to support business building around energy transition, impact, and ESG goals.
Voyager VenturesInvests in energy, industrial, climate, and software companies improving energy use, materials production, carbon management, mobility, buildings, logistics, and manufacturing systems.
8VCBuilds and invests in technology companies, partnering with entrepreneurs to develop platforms addressing areas such as healthcare, zero-emission aircraft, privacy enforcement, and urban tunneling.
Chai DiscoveryBuilds computer-aided molecular design software that models biochemical structure and interaction, helping scientists design new medicines and molecules on computers.
Numerion LabsBuilds an AI platform that searches chemical space for novel drug-like molecules, supporting small-molecule drug discovery programs for immune and inflammatory diseases.